Diagnos Inc. (ADK.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 359 | 958 | 325 | 225 | 570 |
| Marketable Securities | 1,001 | 502 | 1,002 | 1,252 | 1,302 |
| Receivables | 176 | 133 | 162 | 253 | 321 |
| TOTAL | $1,591 | $1,644 | $1,549 | $1,862 | $2,338 |
| Non-Current Assets | |||||
| PPE Net | 328 | 353 | 368 | 57 | 65 |
| Investments And Advances | 32 | 31 | 31 | 31 | 31 |
| TOTAL | $359 | $384 | $399 | $88 | $96 |
| Total Assets | $1,950 | $2,028 | $1,949 | $1,950 | $2,434 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 125 | 125 | 275 | 272 | 268 |
| Accounts payable and accrued liabilities | 190 | 225 | 113 | 99 | 68 |
| Accrued Expenses | 152 | 133 | 144 | 117 | 199 |
| TOTAL | $550 | $583 | $650 | $531 | $581 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39 | 39 | 40 | 40 | N/A |
| Deferred Revenues | 4 | 10 | 11 | 0 | 4 |
| TOTAL | $268 | $278 | $297 | $71 | $34 |
| Total Liabilities | $818 | $861 | $947 | $602 | $615 |
| Shareholders' Equity | |||||
| Common Shares | 34,757 | 34,354 | 33,667 | 33,667 | 33,667 |
| Retained earnings | -42,384 | -41,754 | -41,181 | -40,829 | -40,333 |
| Other shareholders' equity | 8,760 | 8,567 | 8,516 | 8,511 | 8,485 |
| TOTAL | $1,132 | $1,167 | $1,002 | $1,349 | $1,819 |
| Total Liabilities And Equity | $1,950 | $2,028 | $1,949 | $1,950 | $2,434 |